FDA accepts Cingulate's drug application for ADHD treatment CTx-1301
Go back to FDA accepts Cingulate's drug application for ADHD treatment CTx-1301| (NASDAQ: CING) | Delayed: 5.02 -0.15 (2.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.17 | 52 Week High | $ | |||
| Open | $5.22 | 52 Week Low | $ | |||
| Day High | $5.28 | P/E | N/A | |||
| Day Low | $5.02 | EPS | $ | |||
| Volume | 94,447 | |||||
| (NASDAQ: CINGW) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 900 | |||||
